Premium
Cytoprotective and Antioxidant Effects of Steen Solution on Human Lung Spheroids and Human Endothelial Cells
Author(s) -
Pagano F.,
Nocella C.,
Sciarretta S.,
Fianchini L.,
Siciliano C.,
Mangino G.,
Ibrahim M.,
Falco E.,
Carnevale R.,
Chimenti I.,
Frati G.
Publication year - 2017
Publication title -
american journal of transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.89
H-Index - 188
eISSN - 1600-6143
pISSN - 1600-6135
DOI - 10.1111/ajt.14278
Subject(s) - nadph oxidase , medicine , transplantation , reactive oxygen species , pharmacology , downregulation and upregulation , umbilical vein , lung , viability assay , immunology , cancer research , chemistry , in vitro , biochemistry , surgery , gene
Respiratory diseases represent a major healthcare burden worldwide. Lung transplantation ( LT x) is the “gold standard” for end‐stage patients, strongly limited by shortage of available/suitable donor lungs. Normothermic ex vivo lung perfusion ( EVLP ) has significantly increased the number of lungs suitable for transplantation. Steen solution is used for EVLP , but the mechanisms involved in its beneficial properties remain to be clarified. We investigated the effects of Steen solution in an in vitro protocol of cold starvation and normothermic recovery on human lung spheroids, named pneumospheres ( PS s), containing epithelial/basal cells, and on endothelial human umbilical vein endothelial cells ( HUVEC ). Steen solution significantly preserved the viability of PS s, reduced reactive oxygen species ( ROS ) release by PS s and HUVEC s, decreased NADPH ‐oxidase ( NOX ) activity in PS s, and reduced inflammatory cytokines expression levels in HUVEC s. Steen solution was able to specifically reduce NADPH oxidase 2 ( NOX 2) isoform activation, particularly in PS s, as detected by soluble‐ NOX 2 peptide and p47‐phosphorylation. Interestingly, a specific NOX 2 inhibitor could partly mimic the pro‐survival effect of Steen on PS s. We provide the first evidence that Steen solution can preserve lung epithelial/progenitor cells viability partially through NOX 2 downregulation, and exert antioxidant effects on parenchymal cells, with consequent ROS reduction. These results suggest that NOX 2 inhibition might be an additional strategy to reduce cellular damage during LT x procedures.